Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
6,899,800
-
Shares change
-
+912,740
-
Total reported value, excl. options
-
$28,769,681
-
Value change
-
+$3,931,364
-
Put/Call ratio
-
4.1%
-
Number of buys
-
31
-
Number of sells
-
10
-
Price
-
$4.17
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q3 2023
As of 30 Sep 2023 Eton Pharmaceuticals, Inc. - Common Stock (ETON) had 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,899,800 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., VANGUARD GROUP INC, Westside Investment Management, Inc., PARADIGM CAPITAL MANAGEMENT INC/NY, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT, LLC, EAM Investors, LLC, Acuitas Investments, LLC, GEODE CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC.
This table shows 58 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.